News Rumours of $1.65bn GSK bid for respiratory partners Vectura GlaxoSmithKline could be poised to acquire its respiratory partner, UK biotech Vectura, for $1.65bn.
News GSK to take blood cancer drug into late-stage trials UK firm to get back into cancer with GSK2857916
News Eyes on GSK as Pfizer prepares to sell consumer division GlaxoSmithKline saw its share price fall 6% yesterday after releasing underwhelming figures in Q3, and leaving investors uncertain about its future dividend payments.
News GSK’s ‘bubble baby’ gene therapy passes NICE’s new stricter ... GlaxoSmithKline’s gene therapy Strimvelis for the treatment of the ultra-rare ‘bubble baby syndrome’ has been approved by NICE.
News FDA approval gained, Glaxo awaits key committee blessing for... The FDA granted approval to GSK's new shingles vaccine Shingrix on Friday, giving the company the green light on one of its important new products.
Partner Content Partner Content Have you seen the agenda for Social Media in Pharma? Updates on Social Media in Pharma
News Biogen, Denali pull Parkinson's drug after failed trial Biogen has stopped development of Denali-partnered Parkinson's disease candidate BIIB122, after it failed to move the needle in a phase 2b trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
